课题基金 / 基金详情

Original and practical total syntheses of antitumor natural products

Original and practical total syntheses of antitumor natural products
抗肿瘤天然产物的原创实用全合成
批准号:
15350028
负责人:
HAYASHI Yujiro
金额:
$7.42万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2006

项目摘要

项目成果

HAYASHI Yujiro的其他基金

相似基金

相关文献

中文摘要
翻译
通过2h -吡喃衍生物的仿生二聚化,合成了环氧喹啉A、B、C和环氧双酚A。前三种天然产物均由Diels-Alder反应得到,而后者则由形式的4+4环加成反应合成,这是一种非常罕见的反应。我们通过从头计算研究了这种4+4环加成的反应机理,发现该反应是通过双基机制进行的。我们还合成了一些具有较强生物活性的天然产物,如lucilactaene、synerazol、pseurotin A、RK-805、fumagillol、FR65814、ovalicin、5- demethyllovalicin、EI-1941-1、EI-1941-2、EI-1941-3、panepophenthrin、nikkomycin B、fostriecin。在这些合成过程中,我们利用有机催化剂开发了几种实用的不对称反应,如在水存在下的直接醛醇反应、Mannich反应、羰基化合物的α-氨基氧化反应和Michael反应。
英文摘要
We have synthesized epoxyquinol A, B, C and epoxytwinol A, by the biomimetic dimerization of 2H-pyran derivatives. The former three natural products were derived by the Diels-Alder reaction, while the latter was synthesized by the formal 4+4 cycloaddition reaction, which is a very rare reaction. We have investigated the reaction mechanism of this 4+4 cycloaddition via ab initio calculation and found that the reaction would proceed via a biradical mechanism. We have also synthesized several natural products with strong biological activities, such as lucilactaene, synerazol, pseurotin A, RK-805, fumagillol, FR65814, ovalicin, 5-demethylovalicin, EI-1941-1, EI-1941-2, EI-1941-3, panepophenanthrin, nikkomycin B, and fostriecin. During these syntheses, we developed several practical asymmetric reactions using oragnocatalysts such as direct aldol reaction in the presence of water, Mannich reaction, α-aminoxylation of carbonyl compounds, and Michael reaction.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.tetlet.2004.03.190
发表时间: 2004-05
期刊: Tetrahedron Letters
影响因子: 1.8
作者: [Y. Hayashi;Wataru Tsuboi;M. Shoji;N. Suzuki]
通讯作者: Y. Hayashi;Wataru Tsuboi;M. Shoji;N. Suzuki
Enantio-and Diastereoselective Total Synthesis of EI-1941-1,-2 and-3, Inhibitors of Interleukin-1β Converting Enzyme, and Biological Properties of Their Derivatives
白细胞介素1β转换酶抑制剂EI-1941-1、-2和-3的对映和非对映选择性全合成及其衍生物的生物学性质
DOI: --
发表时间: 2005
期刊: J. Org. Chem. 70
影响因子: --
作者: [J.Yamaguchi, I.Shiina, M.Matuszawa, J.Yamaguchi, M.Matuszawa, M.Matsuzawa, I.Shiina, M.Shoji, J.Yamaguchi, Y.Hayashi, Y.Hayashi, M.Shoji, M.Shoji, Y.Hayashi, M.Shoji]
通讯作者: M.Shoji
林 雄二郎: "Asymmetric total Synthesis of Pseurotin A"Org.Lett.. 5・13. 2287-2290 (2003)
Yujiro Hayashi:“Pseurotin A 的不对称全合成”Org.Lett.. 5・13(2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Determination by asymmetric total synthesis of the absolute configuration of lucilactaene, a cell cycle inhibitor in p53-transfected cells
通过不对称全合成测定 p53 转染细胞中细胞周期抑制剂 lucilactaene 的绝对构型
DOI: --
发表时间: 2005
期刊: Angew. Chem. Int. Ed. 44
影响因子: --
作者: [J.Yamaguchi, I.Shiina, M.Matuszawa, J.Yamaguchi, M.Matuszawa, M.Matsuzawa, I.Shiina, M.Shoji, J.Yamaguchi]
通讯作者: J.Yamaguchi
共 22 条
    Development of scanning three-dimensional x-ray diffraction microscopy and in-situ observation of plastic deformation of polycrystalline metals
    • 批准号:
      22760571
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.58万
    • 财政年份:
      2010
    • 负责人:
      HAYASHI Yujiro
    • 依托单位:
    Hierachical Study on Heat Transfer and Viability of Cell during Freezing of Biological Tissue
    • 批准号:
      07405011
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $12.22万
    • 财政年份:
      1995
    • 负责人:
      HAYASHI Yujiro
    • 依托单位:
    Development of Composite-and-Functional Gradient Material by using Supercooling
    • 批准号:
      06555059
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $7.62万
    • 财政年份:
      1994
    • 负责人:
      HAYASHI Yujiro
    • 依托单位:
    Microbehavior and heat transfer during freezing of biological substances
    • 批准号:
      04452146
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $4.03万
    • 财政年份:
      1992
    • 负责人:
      HAYASHI Yujiro
    • 依托单位:
    海外基金